182 related articles for article (PubMed ID: 11503945)
21. Enhancement of frequency domain indices of heart rate variability by cholinergic stimulation with pyridostigmine bromide.
Zarei AA; Foroutan SA; Foroutan SM; Erfanian Omidvar A
Iran J Pharm Res; 2011; 10(4):889-94. PubMed ID: 24250427
[TBL] [Abstract][Full Text] [Related]
22. The effect of pyridostigmine on respiratory function in healthy and asthmatic volunteers.
Ram Z; Molcho M; Danon YL; Almog S; Baniel J; Karni A; Shemer J
Isr J Med Sci; 1991; 27(11-12):664-8. PubMed ID: 1757243
[TBL] [Abstract][Full Text] [Related]
23. Cholinergic stimulation with pyridostigmine protects myocardial infarcted rats against ischemic-induced arrhythmias and preserves connexin43 protein.
Santos-Almeida FM; Girão H; da Silva CA; Salgado HC; Fazan R
Am J Physiol Heart Circ Physiol; 2015 Jan; 308(2):H101-7. PubMed ID: 25416192
[TBL] [Abstract][Full Text] [Related]
24. Effects of Heart Rate Reduction With Either Pyridostigmine or Ivabradine in Patients With Heart Failure: A Randomized, Double-Blind Study.
Villacorta AS; Villacorta H; Caldas JA; Precht BC; Porto PB; Rodrigues LU; Neves M; Xavier AR; Kanaan S; Mesquita CT; da Nóbrega ACL
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):139-145. PubMed ID: 30198318
[TBL] [Abstract][Full Text] [Related]
25. Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes.
Dewland TA; Androne AS; Lee FA; Lampert RJ; Katz SD
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H86-92. PubMed ID: 17322413
[TBL] [Abstract][Full Text] [Related]
26. Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia.
Castro RR; Porphirio G; Serra SM; Nóbrega AC
Heart; 2004 Oct; 90(10):1119-23. PubMed ID: 15367503
[TBL] [Abstract][Full Text] [Related]
27. Ocular effects of hyoscine in double dose transdermal administration and its reversal by low dose pyridostigmine.
Alhalel A; Ziv I; Versano D; Ruach M; Alkalay M; Almog S; Izraeli S; Glovinsky J
Aviat Space Environ Med; 1995 Nov; 66(11):1037-40. PubMed ID: 8588791
[TBL] [Abstract][Full Text] [Related]
28. Parasympathetic activation by pyridostigmine on chemoreflex sensitivity in heart-failure rats.
Sabino JP; da Silva CA; Giusti H; Glass ML; Salgado HC; Fazan R
Auton Neurosci; 2013 Dec; 179(1-2):43-8. PubMed ID: 23911533
[TBL] [Abstract][Full Text] [Related]
29. Pyridostigmine prevents haemodynamic alterations but does not affect their nycthemeral oscillations in infarcted mice.
Corrêa WG; Durand MT; Becari C; Tezini GC; do Carmo JM; de Oliveira M; Prado CM; Fazan R; Salgado HC
Auton Neurosci; 2015 Jan; 187():50-5. PubMed ID: 25434306
[TBL] [Abstract][Full Text] [Related]
30. Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure.
Serra SM; Costa RV; Teixeira De Castro RR; Xavier SS; Nóbrega AC
J Card Fail; 2009 Mar; 15(2):124-9. PubMed ID: 19254671
[TBL] [Abstract][Full Text] [Related]
31. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
Aronson D; Burger AJ
Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
[TBL] [Abstract][Full Text] [Related]
32. The late growth hormone rise induced by oral glucose is enhanced by cholinergic stimulation with pyridostigmine in normal subjects.
Valcavi R; Zini M; Davoli S; Portioli I
Clin Endocrinol (Oxf); 1992 Oct; 37(4):360-4. PubMed ID: 1483293
[TBL] [Abstract][Full Text] [Related]
33. Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans.
Zimerman LI; Liberman A; Castro RR; Ribeiro JP; Nóbrega AC
Braz J Med Biol Res; 2010 Feb; 43(2):211-6. PubMed ID: 20084332
[TBL] [Abstract][Full Text] [Related]
34. Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure.
Venkatesh G; Fallen EL; Kamath MV; Connolly S; Yusuf S
Heart; 1996 Aug; 76(2):137-43. PubMed ID: 8795476
[TBL] [Abstract][Full Text] [Related]
35. The effect of ondansetron on pyridostigmine-induced blood acetylcholinesterase inhibition in the guinea pig.
Capacio BR; Byers CE; Anderson DR; Matthews RL; Brown DE
Drug Chem Toxicol; 1996; 19(1-2):1-19. PubMed ID: 8804550
[TBL] [Abstract][Full Text] [Related]
36. Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability.
Bonnemeier H; Richardt G; Potratz J; Wiegand UK; Brandes A; Kluge N; Katus HA
J Cardiovasc Electrophysiol; 2003 Aug; 14(8):791-9. PubMed ID: 12890036
[TBL] [Abstract][Full Text] [Related]
37. Chronic cholinergic stimulation promotes changes in cardiovascular autonomic control in spontaneously hypertensive rats.
Blanco JH; Gastaldi AC; Gardim CB; Araujo JE; Simões MV; Oliveira LF; Carvalho EE; Souza HC
Auton Neurosci; 2015 Dec; 193():97-103. PubMed ID: 26471065
[TBL] [Abstract][Full Text] [Related]
38. [Changes in autonomic control of heart rate after ischemic cerebral stroke].
Lakusić N; Mahović D; Babić T; Sporis D
Acta Med Croatica; 2003; 57(4):269-73. PubMed ID: 14639860
[TBL] [Abstract][Full Text] [Related]
39. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
Schreglmann SR; Büchele F; Sommerauer M; Epprecht L; Kägi G; Hägele-Link S; Götze O; Zimmerli L; Waldvogel D; Baumann CR
Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
[TBL] [Abstract][Full Text] [Related]
40. Effects of chronic cholinergic stimulation associated with aerobic physical training on cardiac morphofunctional and autonomic parameters in spontaneously hypertensive rats.
Gardim CB; Veiga AC; Aguilar BA; Philbois SV; Souza HCD
Sci Rep; 2021 Aug; 11(1):17141. PubMed ID: 34433865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
